<DOC>
	<DOC>NCT01456520</DOC>
	<brief_summary>This study aims to determine whether the hydrocodone and acetaminophen exposures following oral dosing of Vycavert are comparable to those following oral dosing of Norco.</brief_summary>
	<brief_title>Pharmacokinetics and Bioequivalence of Vycavert (10 mg Hydrocodone Bitartrate/325 mg Acetaminophen) Compared to the Reference Drug Norco</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Healthy male and/or female subjects between the ages of 18 and 55 years, inclusive Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg (110 lbs). Evidence or history of clinically significant disease History of obstructive sleep apnea Life time history and/or recent evidence of alcohol and/or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>bioequivalence</keyword>
	<keyword>hydrocodone</keyword>
	<keyword>acetaminophen</keyword>
	<keyword>moderate to moderately severe pain</keyword>
</DOC>